Joanna Osmanska

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

External validation of the BAN-ADHF diuretic-resistance score in the DAPA-RESIST clinical trial.

External validation of the BAN-ADHF diuretic-resistance score in the DAPA-RESIST clinical trial.

Journal: British journal of clinical pharmacology
Published: January 28, 2026

Severe kidney disease and heart failure therapy: a conundrum only partially resolved.

Severe kidney disease and heart failure therapy: a conundrum only partially resolved.

Journal: European journal of heart failure
Published: January 06, 2026

Cardiac myosin-binding protein C in community-based patients with suspected heart failure.

Cardiac myosin-binding protein C in community-based patients with suspected heart failure.

Journal: European journal of heart failure
Published: December 16, 2025

SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure.

SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure.

Journal: European journal of heart failure
Published: September 17, 2025

Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure.

Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure.

Journal: European journal of heart failure
Published: April 08, 2025

Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF).

Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF).

Journal: European journal of heart failure
Published: July 26, 2024

Subcutaneous furosemide in heart failure: a systematic review.

Subcutaneous furosemide in heart failure: a systematic review.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: July 18, 2024

Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.

Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.

Journal: European journal of heart failure
Published: April 12, 2024

Reply: subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'.

Reply: subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 07, 2024

Preconception counselling in women of reproductive age attending cardiology clinics in Scotland.

Preconception counselling in women of reproductive age attending cardiology clinics in Scotland.

Journal: Heart (British Cardiac Society)
Published: November 05, 2023

A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.

A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: July 22, 2023

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.

Journal: European heart journal
Published: April 14, 2023
Showing 1-12 of 20

Last Updated: 09/26/2026